NCT04774718 2026-03-06A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsHoffmann-La RochePhase 1/2 Recruiting42 enrolled